Cargando…

Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma

BACKGROUND: Metastasis-associated in colon cancer-1 (MACC1) is a newly identified gene that plays a role in colon cancer metastasis through upregulation of c-MET proto-oncogene (c-MET). However, the value of MACC1 as a potential biomarker for hepatocellular carcinoma (HCC) remains unknown. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Jiliang, Huang, Pinzhu, Liu, Qian, Hong, Jian, Li, Binkui, Lu, Canliang, Wang, Li, Wang, Jianping, Yuan, Yunfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192685/ https://www.ncbi.nlm.nih.gov/pubmed/21955323 http://dx.doi.org/10.1186/1479-5876-9-166

Ejemplares similares

Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: A long-term follow-up study
por: Zeng, Qing-An, et al.
Publicado: (2012)

MACC1 as a Prognostic Biomarker for Early-Stage and AFP-Normal Hepatocellular Carcinoma
por: Xie, Chan, et al.
Publicado: (2013)

A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma
por: Lin, Zhu, et al.
Publicado: (2023)

SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial‐mesenchymal transition
por: Zhang, Yuanping, et al.
Publicado: (2021)

NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3
por: Zhang, Yuanping, et al.
Publicado: (2022)

ITPKA expression is a novel prognostic factor in hepatocellular carcinoma
por: Li, Jianbiao, et al.
Publicado: (2015)

METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
por: Bi, Fangfang, et al.
Publicado: (2023)

Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
por: Li, Binkui, et al.
Publicado: (2021)

Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study
por: He, Wei, et al.
Publicado: (2020)

MACC1 expression levels as a novel prognostic marker for colorectal cancer
por: YAMAMOTO, HIROFUMI, et al.
Publicado: (2014)

Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study
por: Qiu, Zhiyu, et al.
Publicado: (2021)

Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study
por: He, Wei, et al.
Publicado: (2018)

MACC1-AS1 promotes hepatocellular carcinoma cell invasion and proliferation by regulating PAX8
por: Tong, Hui, et al.
Publicado: (2020)

Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis
por: Liu, Wenwu, et al.
Publicado: (2019)

Effects of MACC1 polymorphisms on hepatocellular carcinoma development and clinical characteristics
por: Lin, Chien-Hua, et al.
Publicado: (2020)

The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis
por: He, Wei, et al.
Publicado: (2015)

Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
por: Wang, Chenwei, et al.
Publicado: (2021)

Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma
por: Liao, Yadi, et al.
Publicado: (2020)

Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
por: Wang, Chenwei, et al.
Publicado: (2022)

TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study
por: Yuan, Yichuan, et al.
Publicado: (2023)

Resection vs Ablation for Multifocal Hepatocellular Carcinomas meeting the Barcelona-Clinic Liver Cancer A Classification: A Propensity Score Matching Study
por: Liu, Wenwu, et al.
Publicado: (2019)

S100A9 Derived from Chemoembolization‐Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression
por: Zhong, Chengrui, et al.
Publicado: (2022)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation
por: Gao, Sheng, et al.
Publicado: (2014)

Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma
por: Li, Keren, et al.
Publicado: (2023)

Identification of KNOP1 as a prognostic marker in hepatocellular carcinoma
por: Zhang, Yaping, et al.
Publicado: (2023)

Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2021)

Significance of plasma MACC1 levels on the prognostic stratification in patients with colorectal cancer
por: Lin, Aifen, et al.
Publicado: (2018)

Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma
por: Zhou, Huandi, et al.
Publicado: (2021)

Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2022)

Diagnostic and prognostic value of serum MACC1 in breast cancer patients
por: Tan, Weige, et al.
Publicado: (2016)

Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma
por: Li, Binkui, et al.
Publicado: (2017)

Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature
por: Huang, Jun, et al.
Publicado: (2014)

Prognostic Characteristics of MACC1 Expression in Epithelial Ovarian Cancer
por: Jeong, Hoiseon, et al.
Publicado: (2018)

Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients
por: Lin, Aifen, et al.
Publicado: (2019)

Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation
por: Liu, Wenwu, et al.
Publicado: (2018)

Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome?
por: Li, Binkui, et al.
Publicado: (2010)

Long Non-Coding RNA MACC1-AS1 Is Involved in Distant Recurrence of Hepatocellular Carcinoma After Surgical Resection
por: Liu, Yujuan, et al.
Publicado: (2020)

Resection versus Resection with Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma Recurrence
por: Tao, Qiang, et al.
Publicado: (2018)

Identification of Prognostic Genes in Hepatocellular Carcinoma
por: Bai, Wenhui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_djub67r758b76slo4ko9leno86